TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $4.91 billion. The enterprise value is $5.07 billion.
| Market Cap | 4.91B |
| Enterprise Value | 5.07B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TMDX has 32.94 million shares outstanding. The number of shares has increased by 7.50% in one year.
| Shares Outstanding | 32.94M |
| Shares Change (YoY) | +7.50% |
| Shares Change (QoQ) | +6.23% |
| Owned by Insiders (%) | 3.26% |
| Owned by Institutions (%) | 108.44% |
| Float | 31.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 213.86 |
| PS Ratio | 16.53 |
| Forward PS | 11.24 |
| PB Ratio | 30.77 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.08 |
| EV / EBITDA | 362.09 |
| EV / EBIT | 3,083.39 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.72, with a Debt / Equity ratio of 3.24.
| Current Ratio | 9.72 |
| Quick Ratio | 8.61 |
| Debt / Equity | 3.24 |
| Debt / EBITDA | 36.85 |
| Debt / FCF | n/a |
| Interest Coverage | 0.12 |
Financial Efficiency
Return on equity (ROE) is -7.20% and return on invested capital (ROIC) is -2.10%.
| Return on Equity (ROE) | -7.20% |
| Return on Assets (ROA) | -1.50% |
| Return on Capital (ROIC) | -2.10% |
| Revenue Per Employee | $508,423 |
| Profits Per Employee | -$17,457 |
| Employee Count | 584 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.08 |
Taxes
| Income Tax | -1.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.31% in the last 52 weeks. The beta is 1.94, so TMDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.94 |
| 52-Week Price Change | +80.31% |
| 50-Day Moving Average | 131.26 |
| 200-Day Moving Average | 86.54 |
| Relative Strength Index (RSI) | 63.17 |
| Average Volume (20 Days) | 719,958 |
Short Selling Information
The latest short interest is 5.98 million, so 18.16% of the outstanding shares have been sold short.
| Short Interest | 5.98M |
| Short Previous Month | 5.76M |
| Short % of Shares Out | 18.16% |
| Short % of Float | 18.77% |
| Short Ratio (days to cover) | 8.17 |
Income Statement
In the last 12 months, TMDX had revenue of $296.92 million and -$10.20 million in losses. Loss per share was -$0.34.
| Revenue | 296.92M |
| Gross Profit | 185.29M |
| Operating Income | -14.22M |
| Pretax Income | -11.65M |
| Net Income | -10.20M |
| EBITDA | 14.01M |
| EBIT | 1.65M |
| Loss Per Share | -$0.34 |
Balance Sheet
The company has $350.72 million in cash and $516.22 million in debt, giving a net cash position of -$165.51 million or -$5.02 per share.
| Cash & Cash Equivalents | 350.72M |
| Total Debt | 516.22M |
| Net Cash | -165.51M |
| Net Cash Per Share | -$5.02 |
| Equity (Book Value) | 159.47M |
| Book Value Per Share | 4.84 |
| Working Capital | 438.08M |
Cash Flow
In the last 12 months, operating cash flow was -$7.80 million and capital expenditures -$195.09 million, giving a free cash flow of -$202.89 million.
| Operating Cash Flow | -7.80M |
| Capital Expenditures | -195.09M |
| Free Cash Flow | -202.89M |
| FCF Per Share | -$6.19 |
Margins
Gross margin is 62.40%, with operating and profit margins of -4.79% and -3.43%.
| Gross Margin | 62.40% |
| Operating Margin | -4.79% |
| Pretax Margin | -3.92% |
| Profit Margin | -3.43% |
| EBITDA Margin | 4.72% |
| EBIT Margin | 0.55% |
| FCF Margin | -68.33% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.50% |
| Shareholder Yield | -7.50% |
| Earnings Yield | -0.21% |
| FCF Yield | -4.14% |
Analyst Forecast
The average price target for TMDX is $122.50, which is -17.77% lower than the current price. The consensus rating is "Buy".
| Price Target | $122.50 |
| Price Target Difference | -17.77% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 33.17% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 5.41 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.41 |
| Piotroski F-Score | 2 |